Oral Session 2-13C MDS：Basic (2)

[OS2-13C-6] Combined Stag2/Runx1 loss causes myelodysplastic syndrome through perturbed enhancer interactions

Yotaro Ochi^1,2, Ayana Kon¹, Toyonori Sakata³, Masahiro Nakagawa¹, Keisuke Kataoka¹, Haruhiko Koseki⁴, Manabu Nakayama⁵, Ryunosuke Saiki¹, Tetsuichi Yoshizato¹, Kenichi Yoshida¹, Akinori Yoda¹, Shinichi Kotani¹, Hiroshi Suzuki⁶, Daisuke Morishita⁷, Masanori Kakuta⁸, Tatsuaki Tsuruyama⁹, Hideki Makishima¹, Yusuke Shiozawa¹, Yasuhito Nanya¹, Eiji Sugihara¹⁰, Takaaki Sato¹⁰, Masashi Sanada¹¹, Akifumi Takaori², Satoru Miyano⁸, Katsuhiko Shirahige³, Seishi Ogawa¹ (1.Tumor and Pathol., Kyoto Univ, Kyoto, Japan, 2.Hematol and Oncol, Kyoto University, Kyoto, Japan, 3.Lab. of Genome Str and Func., Tokyo univ, Tokyo, Japan, 4.Develop Genet, RIKEN, Yokohama, Japan, 5.Chr Eng Team, Kazusa DNA Res Inst., Kisarazu, Japan, 6.David H. Koch Inst. Cambridge, MA, USA, 7.Chordia Therapeutics Inc, Kanazawa, Japan, 8.Lab of DNA Inf Ana, HGC, Tokyo Univ, Tokyo, Japan, 9.Drug and Discov, Kyoto Univ., Kyoto, Japan, 10.Innov Med Res Inst., Tsukuba Univ., Ibaraki, Japan, 11.Adv Diag, Nagoya Med Center, Nagoya, Japan)